BeiGene selects GE’s FlexFactory™ biomanufacturing platform for pilot cGMP production facility in China
CHALFONT ST. GILES, UK and BEIJING, CHINA – 16 December 2015 – GE Healthcare’s Life Sciences business and BeiGene, Ltd. today announced that BeiGene has selected GE’s FlexFactory™ biomanufacturing platform for its first current Good Manufacturing Practices (cGMP) biomanufacturing facility in Suzhou, China. Currently under construction, the facility is expected to be operational by 2017.... Read more